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nHuman fasciolosis diagnosed in
the  acute phase: A ﬁrst clinical
report in Mexico
Fasciolosis humana diagnosticada en fase
aguda. Primer reporte clínico en México
Fasciolosis  is  a  zoonosis  caused  by  Fasciola  hepatica  that
affects  sheep,  cattle,  and  occasionally,  humans.  In  the  lat-
ter,  2  phases  are  distinguished:  the  acute  phase  and  the
chronic  phase.1
Figure  1  one  illustrates  the  sequential  biologic  cycle.2
Acute  phase  symptomatology  is  fever  of  38 ◦C,  impor-
tant  eosinophilia,  abdominal  skin  rash,  and  pain  in  the
right  hypochondrium.  Diagnostic  methods  in  this  phase  are
a  complete  blood  count  that  shows  blood  eosinophilia  and
anti-Fasciola  hepatica  antibodies.  Stool  exams  in  this  phase
are  negative.3
The  chronic  phase  is  characterized  by  adult  Fasciola  in
the  biliary  tract,  causing  diarrhea  that  can  be  steatorrheic,
fever,  pain  in  the  right  hypochondrium,  and  weight  loss.
Eosinophilia  can  be  mild  or  absent  and  eggs  are  found  in
fecal  material.4,5
We  present  herein  the  clinical  case  of  a  34-year-old  man,
resident  of  Puebla,  Mexico,  that  stated  during  the  medical
interview  that  he  had  eaten  ﬁsh  with  some  type  of  green
topping  one  week  before  symptom  onset,  which  was  charac-
terized  by  a  skin  rash  on  his  face,  neck  and  chest,  ﬂatulence
with  borborygmi,  and  liquid  stools  with  no  blood  (3  in  24  h).
The  patient  then  presented  with  fever  of  38 ◦C,
headache,  myalgia,  pain  in  the  right  hypochondrium  that
radiated  to  the  ipsilateral  lumbar  region,  and  weight  loss  of
4  kg  in  3  weeks.
The  Widal  test  was  negative,  but  due  to  the  clinical  sus-
picion  of  typhoid  fever,  he  was  given  3  g  daily  of  ampicillin
for  10  days  with  no  improvement.
 Please cite this article as: Cruz y López OR, Gómez de la Vega E,
Cárdenas-Perea ME, Gutiérrez-Dávila A, Tamariz-Cruz OJ. Fasciolo-
sis humana diagnosticada en fase aguda. Primer reporte clínico en
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hBecause  of  the  lack  of  treatment  response,  the  patient
ought  medical  attention  at  the  Clinical  Parasitology  Service
f  the  Faculty  of  Medicine  of  the  BUAP. New  labora-
ory  tests  reported:  complete  blood  count:  erythrocytes
.9  mm3, hemoglobin  14.5  g/dL,  hematocrit  45%,  MCV  91  ﬂ,
CHC  32  g/dL.  Leukocytes  9.15  thousand/L, with  differ-
ntial  count  of:  lymphocytes  2.19  thousand/L neutrophils
.56  thousand/L, eosinophils  4.11,  thousand/L  basophils
.18  thousand/L, and  monocytes  0.09  thousand/L.
Because  of  the  high  percentage  of  eosinophils,  complete
lood  count  was  repeated  8  days  later  with  the  follow-
ng  results:  erythrocytes  5.0  mm3, hemoglobin  14.7  g/dL,
ematocrit  46%,  leukocytes  10.87  thousand/L,  lympho-
ytes  1.63  thousand/L, neutrophils  2.82  L,  eosinophils
.19  thousand/L, basophils  0.0  thousand/L, and  mono-
ytes  0.21  thousand/L.
The stool  exams  were  performed  using  the  sedimentation
echnique.  Six  samples  were  negative  and  Enterotest® (Beal
apsule)  was  negative  for  cysts,  trophozoites,  and  parasitic
ggs.
Counterimmunoelectrophoresis  (CIE)  was  carried  out  to
earch  for  anti-Fasciola  hepatic  antibodies  (ﬁg.  2).
The  patient  was  treated  with  1  mg/kg  of  weight  of  intra-
uscular  dehydroemetine  for  10  days  with  total  symptom
emission.
The  present  case  corresponds  to  acute  (or  invasive)  phase
asciolosis  and  is  the  ﬁrst  of  its  kind  to  be  reported  in
exico.  In  Peru,  where  fasciolosis  is  endemic,  a  review
arried  out  from  1963  to  2005  reported  a total  of
,701  cases,  only  11%  of  which  were  diagnosed  in  the  inva-
ive  phase  and  89%  were  diagnosed  with  full-blown  disease,
orroborating  the  difﬁculty  of  diagnosis  in  the  acute  phase.6
s  illustrated  by  the  present  report,  due  to  its  polymor-
hic  symptomatology,  physicians  do  not  usually  consider  this
athology  in  the  differential  diagnosis  and  patients  undergo
umerous  studies  and  treatments  before  being  correctly
iagnosed.7
An  important  datum  is  a  history  of  watercress  ingestion,
hich  has  been  identiﬁed  in  national  studies  in  up  to  49%  of
he  cases;  this  history  was  not  obtained  or  was  not  reported
n  23  and  28%  of  the  cases,  respectively.  Our  patient  stated
hat  he  was  not  familiar  with  watercress,  but  he  did  say
e  had  eaten  a  vegetable  topping  before  clinical  symptom
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Figure  1  The  habitat  of  adult  Fasciola  hepatica  is  in  the  bile  ducts  of  sheep  (1,2).  When  the  eggs  are  passed  into  an  aquatic
environment through  feces  (3),  a  ciliated  parasite  (miracidium)  develops  inside  them  (4,  5)  that  searches  for  a  Lymnaeidae  snail  (6)
and transforms  inside  it  into  a  sporocyst,  mother  redia,  daughter  redia,  and  cercaria  (7,  8,  9).  The  latter  abandons  the  snail  (10)
adopting the  cystic  form  of  a  metacercaria  (11)  and  adheres  to  different  aquatic  plants  that  are  eaten  by  sheep  (12).  It  reaches
the duodenum,  forming  tunnels  in  the  tissue  until  reaching  the  liver  (1,  2).  The  acute  phase  in  humans  begins  when  an  individual
becomes infected  by  eating  watercress  (Nasturtium  ofﬁcinale)  that  contains  metacercariae,  transforming  in  the  duodenum  into
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ddolocercariae  (13-15).  They  penetrate  the  tissues  through  prot
n a  period  of  4  to  6  months.  The  habitat  of  the  adult  Fasciola  
hat can  last  months  or  years  (16,17).  (Source:  Modiﬁed  from:  C
nset.  Recent  reports  link  fasciolosis  with  radish  ingestion,
nd  to  a  lesser  degree  with  the  ingestion  of  turnips,  spinach,
nd  lettuce,  results  that  require  further  investigation.8
And  ﬁnally,  our  patient  was  treated  with  dehydroeme-
ine,  due  to  the  nonavailability  of  the  drug  that  is  currently
onsidered  the  treatment  of  choice:  triclabendazole  at  anigure  2  Counterimmunoelectrophoresis.  Upper  wells:  con-
rols; lower  wells:  patient  and  control.
F
Ns  until  reaching  the  liver  parenchyma,  adopting  the  adult  form
the  bile  ducts,  causing  the  chronic  or  full-blown  disease  phase
López  O.2
ral  dose  of  10  mg/Kg.  Studies  have  reported  the  usefulness
f  nitazoxanide,  but  the  results  are  still  inconclusive.9
We  presented  this  report  in  the  hope  it  can  be  useful
n  the  study  of  patients  with  eosinophilia  and  their  early
reatment.
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Proton pump
inhibitor-responsive esophageal
eosinophilia: A new entity in
search of recognition?
Eosinoﬁlia esofágica sensible a inhibidores de
la bomba de protones. ¿Nueva entidad en
busca de reconocimiento?
Eosinophilic  esophagitis  (EoE)  has  been  a  well-recognized
pathologic  entity  in  adults  since  1978.  Its  clinical  charac-
teristics,  treatment,  and  progression  have  been  extensively
studied  over  the  last  years.  However,  it  has  recently
been  described  to  form  part  of  a  group  of  clinical  enti-
ties  characterized  by  the  inﬁltration  of  eosinophils  in
the  esophageal  mucosa  together  with  gastroesophageal
reﬂux  disease  (GERD)  and  proton-pump  inhibitor-responsive
esophageal  eosinophilia  (PPI-REE).  Based  on  the  above,
we  decided  to  present  herein  the  case  of  a  patient  with
esophageal  eosinophilic  inﬁltration  diagnosed  with  PPI-REE,
given  his  favorable  response  to  these  drugs.
A  50-year-old  man  sought  medical  attention  due  to  inter-
mittent  dysphagia,  retrosternal  pain,  and  heartburn.  He
had  a past  history  of  hemorrhoidectomy  and  appendectomy
years  before  and  seafood  allergy.  Six  months  earlier,  he  had
been  seen  by  another  gastroenterologist  for  the  same  symp-
toms,  underwent  endoscopy  with  no  esophageal  biopsy,  was
diagnosed  with  esophageal  candidiasis,  and  prescribed  oral
nystatin.  His  blood  count  and  biochemical  proﬁle  were  nor-
mal.
We  decided  to  perform  another  endoscopy  and  it
revealed  an  abundant  whitish  mottled  pattern  in  the
esophageal  mucosa  with  some  areas  of  exudate  and  edema
(Fig.  1A).  No  hiatal  hernia  or  erosions  were  observed  and
the  junctional  epithelium  had  a normal  aspect.  Eight  biopsy
samples  were  taken  from  the  mucosa  of  the  upper  and  lower
third  of  the  esophagus  and  the  pathologist  reported  the
presence  of  an  abundant  eosinophilic  inﬁltrate  in  the  epithe-
lium  (from  18  to  52  per  high  power  ﬁeld  [HPF])  (Fig.  1B).
Twenty-four  hour  esophageal  pH  impedance  monitoring  was Please cite this article as: García-Compeán D, González-
González JA, González-Moreno EI, Barrera-Villarreal E,
Maldonado-Garza HJ. Eosinoﬁlia esofágica sensible a inhibidores
de la bomba de protones. ¿Nueva entidad en busca de
reconocimiento? Revista de Gastroenterología de México. 2016;82:
113--115.
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sormal.  The  patient  was  treated  with  40  mg  of  oral  pan-
oprazole  every  12  h  for  2  months.  After  that  treatment,
ndoscopy  with  biopsy  was  repeated,  which  showed  endo-
copic  improvement  of  the  mucosa  (Fig.  2A),  and  in  the
iopsy  there  was  signiﬁcant  reduction  of  the  eosinophilic
nﬁltrate  (1  to  3  eosinophils  per  HPF)  (Fig.  2B).  The  patient
tated  that  he  had  a  signiﬁcant  decrease  in  the  intensity  of
